http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005020799-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3248f905088670e374b232222a6b7177
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-065
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-70535
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-566
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-566
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
filingDate 2004-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3537bd1ea49df337ec02666209f57e26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a54c28e81043f02eed3cc6c31d0a42f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1bbf7a5e589851f1e7c79d1f0fae786c
publicationDate 2005-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2005020799-A3
titleOfInvention METHOD FOR MEASURING FC&epsiv;RII/CD23 IGE RECEPTOR IN HUMAN FECES AS AN INDICATOR OF A TH2 PREDOMINANT IMMUNE RESPONSE INVOLVED IN GASTROINTESTINAL ILLNESSES
abstract A method and apparatus for measuring Fc&epsiv;RII/CD23 IgE receptor in human feces or other biological specimens as an indicator of a TH2 immune response indicative of gastrointestinal illnesses such as ulcerative colitis and food allergy is described. The apparatus consists of either a qualitative or quantitative enzyme-linked immunoassay or other immunoassay that utilizes antibodies specific to human Fc&epsiv;RII/CD23 IgE receptor for the measurement of endogenous Fc&epsiv;RII/CD23 IgE receptor in human feces. The method and apparatus can be used by healthcare providers as an aid for determining gastrointestinal illnesses that are predominantly a TH2 predominant immune response such as ulcerative colitis, large bowel Crohn's disease (UC-like Crohn's disease), allergic colitis (food allergy) and parasitic infections.
priorityDate 2003-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6410714-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5124252-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396401
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20055127

Total number of triples: 24.